- Home
- CLIR vs TPST Comparison
CLIR vs TPST Comparison
Compare CLIR & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- TPST
- Stock Information
- Founded
- CLIR 2008
- TPST 2011
- Country
- CLIR United States
- TPST United States
- Employees
- CLIR N/A
- TPST N/A
- Industry
- CLIR Industrial Machinery/Components
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- CLIR Industrials
- TPST Health Care
- Exchange
- CLIR Nasdaq
- TPST Nasdaq
- Market Cap
- CLIR 32.5M
- TPST 33.0M
- IPO Year
- CLIR 2012
- TPST N/A
- Fundamental
- Price
- CLIR $0.54
- TPST $7.08
- Analyst Decision
- CLIR Strong Buy
- TPST Hold
- Analyst Count
- CLIR 1
- TPST 3
- Target Price
- CLIR $2.00
- TPST $30.00
- AVG Volume (30 Days)
- CLIR 49.8K
- TPST 241.4K
- Earning Date
- CLIR 08-13-2025
- TPST 08-07-2025
- Dividend Yield
- CLIR N/A
- TPST N/A
- EPS Growth
- CLIR N/A
- TPST N/A
- EPS
- CLIR N/A
- TPST N/A
- Revenue
- CLIR $2,895,000.00
- TPST N/A
- Revenue This Year
- CLIR $27.61
- TPST N/A
- Revenue Next Year
- CLIR $116.19
- TPST N/A
- P/E Ratio
- CLIR N/A
- TPST N/A
- Revenue Growth
- CLIR 10.88
- TPST N/A
- 52 Week Low
- CLIR $0.46
- TPST $5.35
- 52 Week High
- CLIR $1.72
- TPST $30.03
- Technical
- Relative Strength Index (RSI)
- CLIR 38.76
- TPST 50.32
- Support Level
- CLIR $0.51
- TPST $6.73
- Resistance Level
- CLIR $0.60
- TPST $7.18
- Average True Range (ATR)
- CLIR 0.06
- TPST 0.29
- MACD
- CLIR -0.01
- TPST 0.00
- Stochastic Oscillator
- CLIR 26.50
- TPST 78.01
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.